Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Investor Presentation

25 Feb 2022

Shield Therapeutics plc announces that it will provide a live investor presentation on Thursday 3 March 2022 at 4.30pm (GMT).

Chief Executive Officer, Greg Madison will present alongside Chief Financial Officer, Hans-Peter Rudolf and Chief Medical Officer, Dr José Menoyo to provide an update to investors following the recent trading statement. Investors can sign up to Investor Meet Company for free and request to meet Shield Therapeutics plc via the following link: https://www.investormeetcompany.com/shield-therapeutics-plc/register-investor

Questions can be submitted pre-event via your IMC dashboard or in real time during the presentation, via the “Ask a Question” function.  Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of regulations and information already disclosed to the market through regulatory notifications. A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards. No new price sensitive information will be disclosed, and a PDF of the presentation will be uploaded to the Company’s website.

For full details click here.

Back to news